Success Metrics

Active Trials
7(100%)

Phase Distribution

Ph phase_2
6
86%
Ph phase_3
1
14%

Phase Distribution

0

Early Stage

6

Mid Stage

1

Late Stage

Phase Distribution7 total trials
Phase 2Efficacy & side effects
6(85.7%)
Phase 3Large-scale testing
1(14.3%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

7

trials recruiting

Total Trials

7

all time

Status Distribution
Active(7)

Detailed Status

Active, not recruiting5
Recruiting2

Development Timeline

Analytics

Development Status

Total Trials
7
Active
7
Success Rate
N/A
Most Advanced
Phase 3

Trials by Phase

Phase 26 (85.7%)
Phase 31 (14.3%)

Trials by Status

active_not_recruiting571%
recruiting229%

Recent Activity

7 active trials
Showing 5 of 7
active_not_recruitingphase_2

Study to Evaluate the Efficacy and Safety of AHB-137 in Treatment-naive Participants With Chronic Hepatitis B (CHB)

NCT06829329
active_not_recruitingphase_2

Study to Evaluate the Efficacy and Safety of AHB-137 Injection in Participants With Chronic Hepatitis B (CHB).

NCT06550128
active_not_recruitingphase_3

Study of AHB-137 in Participants With Chronic Hepatitis B (CHB) Treated With Nucleos(t)Ide Analogues (NAs)(AUSHINE)

NCT07246889
active_not_recruitingphase_2

A Study to Evaluate the Antiviral Activity and Immune Response of AHB-137 Injection in Participants With Chronic Hepatitis B (CHB)

NCT06993480
recruitingphase_2

A Study to Evaluate the Efficacy and Safety of AHB-137 Injection in Participants With Chronic Hepatitis B (CHB)

NCT07137910
View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials
NCT06829329Phase 2

Study to Evaluate the Efficacy and Safety of AHB-137 in Treatment-naive Participants With Chronic Hepatitis B (CHB)

Active Not Recruiting
NCT06550128Phase 2

Study to Evaluate the Efficacy and Safety of AHB-137 Injection in Participants With Chronic Hepatitis B (CHB).

Active Not Recruiting
NCT07246889Phase 3

Study of AHB-137 in Participants With Chronic Hepatitis B (CHB) Treated With Nucleos(t)Ide Analogues (NAs)(AUSHINE)

Active Not Recruiting
NCT06993480Phase 2

A Study to Evaluate the Antiviral Activity and Immune Response of AHB-137 Injection in Participants With Chronic Hepatitis B (CHB)

Active Not Recruiting
NCT07137910Phase 2

A Study to Evaluate the Efficacy and Safety of AHB-137 Injection in Participants With Chronic Hepatitis B (CHB)

Recruiting
NCT07370207Phase 2

Phase 2 Study of AHB-137 in HBeAg Negative Chronic Hepatitis B (CHB) Participants in Asia Pacific Region

Recruiting
NCT07069569Phase 2

A Multicenter Study of AHB-137 Injection Combined With Other Hepatitis B Drugs

Active Not Recruiting

All 7 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
7